Tuberculosis - collaboration to target disease

For the past 20 years the number of cases of TB has been on the rise, in part because conventional antibiotic treatment has become less and less effective. South Africa is a region especially badly affected by TB. Stefan H.E. Kaufmann, who heads the Max Planck Institute for Infection Biology in Berlin, has set up a research group there in collaboration with the University of KwaZulu-Natal and an American biomedical research institute.